On May 19, 2023, CVS Health Corporation (NYSE: CVS) opened at $69.34, higher 0.10% from the last session. During the day, the shares moved up to $69.89 and dropped to $69.14 before settling in for the closing price of $69.31. Price fluctuations for CVS have ranged from $67.05 to $107.26 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 11.80%. Company’s average yearly earnings per share was noted -47.30% at the time writing. With a float of $1.28 billion, this company’s outstanding shares have now reached $1.28 billion.
The extent of productivity of a business whose workforce counts for 300000 workers is very important to gauge. In terms of profitability, gross margin is +16.92, operating margin of +5.08, and the pretax margin is +1.74.
CVS Health Corporation (CVS) Insider Updates
A key investor’s attitude towards the stock of the Healthcare Plans industry is another important factor to consider. The insider ownership of CVS Health Corporation is 0.10%, while institutional ownership is 80.70%. The most recent insider transaction that took place on May 03, was worth 976,567. In this transaction President and CEO of this company bought 14,000 shares at a rate of $69.75, taking the stock ownership to the 431,392 shares. Before that another transaction happened on Dec 15, when Company’s EVP & General Counsel sold 137,466 for $98.36, making the entire transaction worth $13,521,180. This insider now owns 608,129 shares in total.
CVS Health Corporation (CVS) Performance Highlights and Predictions
If we go through the results of last quarter, which was made public on 3/30/2023, the company posted $2.2 earnings per share (EPS) for the quarter, besting the agreed prediction (set at $2.09) by $0.11. This company achieved a net margin of +1.29 while generating a return on equity of 5.68. Wall Street market experts anticipate that the next fiscal year will bring earnings of 2.2 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -47.30% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 4.00% during the next five years compared to -8.90% drop over the previous five years of trading.
CVS Health Corporation (NYSE: CVS) Trading Performance Indicators
Check out the current performance indicators for CVS Health Corporation (CVS). In the past quarter, the stock posted a quick ratio of 0.70. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.27. Likewise, its price to free cash flow for the trailing twelve months is 6.15.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 3.04, a number that is poised to hit 2.14 in the next quarter and is forecasted to reach 8.91 in one year’s time.
Technical Analysis of CVS Health Corporation (CVS)
The latest stats from [CVS Health Corporation, CVS] show that its last 5-days average volume of 9.0 million was inferior to 9.02 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 63.27%. Additionally, its Average True Range was 1.43.
During the past 100 days, CVS Health Corporation’s (CVS) raw stochastic average was set at 8.73%, which indicates a significant decrease from 34.88% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 28.85% in the past 14 days, which was higher than the 20.91% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $73.29, while its 200-day Moving Average is $89.50. Now, the first resistance to watch is $69.80. This is followed by the second major resistance level at $70.22. The third major resistance level sits at $70.55. If the price goes on to break the first support level at $69.05, it is likely to go to the next support level at $68.72. Assuming the price breaks the second support level, the third support level stands at $68.30.
CVS Health Corporation (NYSE: CVS) Key Stats
There are currently 1,282,025K shares outstanding in the company with a market cap of 88.86 billion. Presently, the company’s annual sales total 322,467 M according to its annual income of 4,149 M. Last quarter, the company’s sales amounted to 85,278 M and its income totaled 2,136 M.
